Skip to content

A mindfulness-based program with VR-based exposures for anxiety disorders -Effectiveness and cost-effectiveness of a randomized controlled feasibility trial-

A mindfulness-based program with VR-based exposures -Effectiveness and cost-effectiveness of a randomized controlled feasibility trial- - A mindfulness-based program with VR-based exposures -a randomized controlled feasibility trial-

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000048112
Enrollment
50
Registered
2022-06-20
Start date
2022-06-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anxiety disorders

Interventions

8 weekly sessions of mindfulness-based program (mindfulness-based cognitive therapy) + 3 sessions of VR-based exposures 8 weekly sessions of mindfulness-based program (mindfulness-based cognitive ther

Sponsors

Keio University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: /Diagnosed as panic disorder, agoraphobia, or social anxiety disorder, based on DSM-4 / No remission after 4 week's pharmacotherapy /Ability to consent in writing

Exclusion criteria

Exclusion criteria: /Substance related disorders /Severe suicidal ideation or self-harm behaviour /Severe general medical conditions /Unsuitable for participation in the research in the opinion of the principal investigator

Design outcomes

Primary

MeasureTime frame
1) enrollment rate, 2) attrition rate, 3)attendance rate

Secondary

MeasureTime frame
mean and standardized deviation of the following clinical parameters at baseline,4, 8, 16weeks : STAI,PAS, LSAS-J, Experiences Questionaire, RSES, FFMQ, CD-RISC, SCS, QIDS, PSS, HPQ, SWLS, FS, EQ-5D.

Countries

Japan

Contacts

Public Contactakira ninomiya

Keio University School of Medicine Department of Neuropsychiatry

akira-ninomiya@keio.jp+81-(0)3-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026